Cannabinoid receptors CB1 and CB2 form functional heteromers in the brain

Exploring the role of cannabinoid CB2 receptors in the brain, we present evidence of CB2 receptor molecular and functional interaction with cannabinoid CB1 receptors. Using biophysical and biochemical approaches, we discovered that CB2 receptors can form heteromers with CB1 receptors in transfected...

Descripción completa

Detalles Bibliográficos
Autores: Callén Herrero, Lucía, Moreno Guillén, Estefanía, Barroso-Chinea, Pedro, Moreno-Delgado, David, Cortés Tejedor, Antonio, Mallol Montero, Josefa, Casadó, Vicent, Lanciego, José Luis, Franco Fernández, Rafael, Lluís i Biset, Carme, Canela Campos, Enric I. (Enric Isidre), 1949-, McCormick, Peter J.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2012
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/122584
Acceso en línea:https://hdl.handle.net/2445/122584
Access Level:acceso abierto
Palabra clave:Receptors cel·lulars
Cervell
Proteïnes
Cell receptors
Brain
Proteins
Descripción
Sumario:Exploring the role of cannabinoid CB2 receptors in the brain, we present evidence of CB2 receptor molecular and functional interaction with cannabinoid CB1 receptors. Using biophysical and biochemical approaches, we discovered that CB2 receptors can form heteromers with CB1 receptors in transfected neuronal cells and in rat brain pineal gland, nucleus accumbens, and globus pallidus. Within CB1-CB2 receptor heteromers expressed in a neuronal cell model, agonist co-activation of CB1 and CB2 receptors resulted in a negative cross-talk in Akt phosphorylation and neurite outgrowth. Moreover, one specific characteristic of CB1-CB2 receptor heteromers consists of both the ability of CB1 receptor antagonists to block the effect of CB2 receptor agonists and, conversely, the ability of CB2 receptor antagonists to block the effect of CB1 receptor agonists, showing a bidirectional cross-antagonism phenomenon. Taken together, these data illuminate the mechanism by which CB2 receptors can negatively modulate CB1 receptor function.